View All Blog Posts

Vaccine Confidence Vital to Curb COVID-19 in MENA

When the COVID-19 pandemic struck more than a year ago, biopharmaceutical companies responded swiftly and worked tirelessly to develop COVID-19 vaccines, treatments and diagnostics. Since then, vaccine candidates have endured rigorous testing through multiple phases of clinical trials and regulatory review. As health authorities continue to monitor the safety and efficacy of these medicines and approve them for public use, it is important for people to know that manufacturers followed a rigorous testing process, including tens of thousands of people.

The Vaccine Confidence Project (VCP) defines vaccine confidence as “the willingness to accept a vaccine once supply, access and information are available.” In simpler terms, vaccine confidence is high when the population that should receive a vaccine considers it safe and effective, and chooses to receive it.

A recent report by the VCP highlights public sentiment regarding the safety and efficacy of vaccines:

  • 61% of respondents in the Middle East strongly agree (18% somewhat agree) that vaccines are safe, while 66% strongly agree (20% somewhat agree) that vaccines are effective.
  • 72% of respondents in North Africa strongly agree (13% somewhat agree) that vaccines are safe, while 71% strongly agree (13% somewhat agree) that vaccines are effective.

As public confidence continues to grow throughout the MENA region, government and private sector officials must build on this already impressive momentum and practice transparency in communication and action. To eradicate the virus and minimize loss of life, patients must feel confident in the safety and efficacy of the vaccine and choose inoculation. The health of people worldwide depends on it.


Recognizing World IP Day Across the Middle East and North Africa

With an expanding labor force and burgeoning economic opportunities, it’s important for leaders in the Middle East and North Africa (MENA) to embrace robust approaches to intellectual property (IP) that encourage investment in innovation. This World IP Day, we explore the theme “Women and IP: Accelerating Innovation and Creativity,” highlighting the essential role of IP

Global Investments in Science and Innovation were Resilient during COVID-19

A new report, Global Innovation Index 2022, from the World Intellectual Property Organization (WIPO) indicates that research and development (R&D) investments thrived at the height of the COVID-19 pandemic in 2020 and continued to boom in 2021. This spike in innovation occurred despite the global recession and economic lockdowns in many countries, pointing to the importance of innovation for pandemic solutions and recovery.

Opportunities for Progress

Explore policy-related opportunities for governments, health officials and companies operating in the MENA health sector.

Learn more